Primary Site >> Biliary tract Cancer
Gene >> DCK
| 1. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2012 Apr 27;421(1):98-104. | ||||||||||
| Title: | DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells. | ||||||||||
| Author: | Saiki, Yuriko|Yoshino, Yuki|Fujimura, Hiroko|Manabe, Tatsuya|Kudo, Yuki|Shimada, Miki|Mano, Nariyasu|Nakano, Tomohiro|Lee, Yoonha|Shimizu, Shinjiro|Oba, Shinya|Fujiwara, Sho|Shimizu, Hideyuki|Chen, Na|Nezhad, Zhaleh Kashkouli|Jin, Guo|Fukushige, Shinichi| | ||||||||||
| PMID: | 22490663 | ||||||||||
| 2. | |||||||||||
| Journal: | Anticancer Res. 2012 Aug;32(8):3211-8. | ||||||||||
| Title: | Establishment and characterization of a new human gallbladder carcinoma cell line. | ||||||||||
| Author: | Sekine, Shinichi|Shimada, Yutaka|Nagata, Takuya|Moriyama, Makoto|Omura, Testuya|Yoshioka, Isaku|Hori, Ryouta|Matsui, Koushi|Sawada, Shigeaki|Okumura, Tomoyuki|Yoshida, Toru|Tsukada, Kazuhiro | ||||||||||
| PMID: | 22843894 | ||||||||||
| 3. | |||||||||||
| Journal: | World J Surg Oncol. 2013 May 27;11:117. | ||||||||||
| Title: | Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone. | ||||||||||
| Author: | Murata, Akihiro|Amano, Ryosuke|Yamada, Nobuya|Kimura, Kenjiro|Yashiro, Masakazu|Nakata, Bunzo|Hirakawa, Kosei | ||||||||||
| PMID: | 23710668 | ||||||||||
| 4. | |||||||||||
| Journal: | Mol Clin Oncol. 2013 Jul;1(4):716-720. | ||||||||||
| Title: | Clinicopathological significance of deoxycytidine kinase expression in esophageal squamous cell carcinoma. | ||||||||||
| Author: | Shimada, Yutaka|Okumura, Tomoyuki|Sekine, Shinichi|Moriyama, Makoto|Hojo, Shozo|Matsui, Koshi|Sawada, Shigeaki|Nagata, Takuya|Fukuoka, Junya|Tsukada, Kazuhiro | ||||||||||
| PMID: | 24649234 | ||||||||||
| 5. | |||||||||||
| Journal: | Oncol Rep. 2014 Aug;32(2):829-34. | ||||||||||
| Title: | Cholangiocarcinoma cell line TK may be useful for the pharmacokinetic study of the chemotherapeutic agent gemcitabine. | ||||||||||
| Author: | Kamada, Minori|Akiyoshi, Kohei|Akiyama, Nobutake|Funamizu, Naotake|Watanabe, Michiko|Fujioka, Kouki|Ikeda, Kei-Ichi|Manome, Yoshinobu | ||||||||||
| PMID: | 24891233 | ||||||||||
| 6. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2015 Sep 4;464(4):1084-9. | ||||||||||
| Title: | Acquisition of chemoresistance to gemcitabine is induced by a loss-of-function missense mutation of DCK. | ||||||||||
| Author: | Nakano, Tomohiro|Saiki, Yuriko|Kudo, Chiharu|Hirayama, Akiyoshi|Mizuguchi, Yasuhiko|Fujiwara, Sho|Soga, Tomoyoshi|Sunamura, Makoto|Matsumura, Nobutoshi|Motoi, Fuyuhiko|Unno, Michiaki|Horii, Akira | ||||||||||
| PMID: | 26196746 | ||||||||||
| 7. | |||||||||||
| Journal: | Oncology. 2015;89(6):345-50. | ||||||||||
| Title: | Cytidine Deaminase as a Molecular Predictor of Gemcitabine Response in Patients with Biliary Tract Cancer. | ||||||||||
| Author: | Yoon, Kyong-Ah|Woo, Sang Myung|Hong, Eun Kyung|Jung, Mee Kyung|Park, Weon Seo|Bae, Kieun|Han, Sung-Sik|Kim, Tae Hyun|Koh, Young Hwan|Park, Sang-Jae|Lee, Woo Jin | ||||||||||
| PMID: | 26418006 | ||||||||||
| 8. | |||||||||||
| Journal: | Oncotarget. 2017 Jul 6;8(46):81394-81404. | ||||||||||
| Title: | DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study. | ||||||||||
| Author: | Woo, Sang Myung|Yoon, Kyong-Ah|Hong, Eun Kyung|Park, Weon Seo|Han, Sung-Sik|Park, Sang-Jae|Joo, Jungnam|Park, Eun Young|Lee, Ju Hee|Kim, Yun-Hee|Kim, Tae Hyun|Lee, Woo Jin | ||||||||||
| PMID: | 29113399 | ||||||||||